Association of Corporate Counsel
Member Login
By in-house counsel, for in-house counsel ®
Search Filters
11 pages
This article breaks down the evolution of the Hospital Price Transparency Rule. This resource highlights new compliance obligations and offers insights into emerging enforcement trends that hospitals should be tracking closely.
Resource Details
Interest Area:
Health Law
Region:
United States
182 pages
This guide provides a compilation of insights from legal practitioners to assist in the identification and understanding of the laws and regulations that impact the drug and medical device industry.
Resource Details
Interest Area:
Litigation and Dispute Resolution,
Health Law
Region:
Global, Australia, Belarus, Chile, China, France, Germany, India, Italy, Japan, Peru, Poland, Spain, Switzerland, Taiwan, Turkey, United Kingdom, United States
278 pages
This guide provides corporate counsel and international practitioners with comprehensive jurisdiction-by-jurisdiction guidance to digital health laws and regulations around the world.
Resource Details
Interest Area:
Health Law
Region:
Global, Argentina, Belarus, Canada, France, Germany, Greece, India, Indonesia, Israel, Italy, Japan, Mexico, Poland, Singapore, South Korea, Switzerland, Taiwan, United Kingdom
3 pages
US Attorney General Pam Bondi has renewed the prior Trump administration’s prohibition on the use of sub-regulatory guidance, potentially altering the landscape for False Claims Act cases pursued during the second Trump administration.
Resource Details
Interest Area:
Health Law,
Government
Region:
United States
5 pages
The provision of patient assistance, including transportation and other free or discounted items and services to patients by health care providers and suppliers implicate certain fraud and abuse laws.
These law include the prohibition on beneficiary inducements under the federal Civil Monetary Penalties (“CMP”) Law and the federal Anti-Kickback Statute (“AKS”).
This article provides a summary of the CMP Law and AKS and certain exceptions under those laws.
Resource Details
Interest Area:
Health Law
Region:
United States
Since its inception in 1992, the 340B Drug Pricing Program (340B Program) has provided eligible health care providers (covered entities) access to significant discounts on the cost of outpatient pharmaceuticals from participating manufacturers.
Over the past 15 years, the 340B Program’s size and scope has expanded due to actions by Congress and the federal Health Resources and Services Administration (HRSA). This article provides an overview of the program's current state.
Resource Details
Interest Area:
Health Law
Region:
United States
7 pages
This sample policy covers medical providers giving financial assistance to eligible patients for costs not covered by insurance.
Resource Details
Interest Area:
Health Law
Region:
United States